肥胖对COPD患者呼吸障碍的影响
Alexis Dupuis1, Aurore Thierry2, Jeanne-Marie Perotin1,3
1Department of Respiratory Diseases, University Hospital of Reims, Reims, France.
概括
肥胖不会使COPD患者的呼吸障碍恶化. 肥胖的COPD患者的肺高通胀和肺气较少,这可能解释了为什么呼吸障碍不会随着疾病的严重程度而增加.
科学领域:
- 肺部病理学 肺部病理学
- 内部医学 内部医学
- 临床研究 临床研究
背景情况:
- 在慢性阻塞性肺病 (COPD) 中,肥胖和呼吸障碍之间的关系尚不清楚.
- 慢性肺炎的管理往往忽视了患者体重对呼吸系统症状的影响.
研究的目的:
- 为了评估COPD患者在不同类别的身体质量指数 (BMI) 中的呼吸障碍.
- 调查肥胖如何影响呼吸障碍严重程度与COPD进展的关系.
主要方法:
- 分析了127名慢性慢性病患者 (BMI ≥18.5公斤/平方米).
- 使用修改的医学研究委员会 (mMRC) 尺度评估呼吸障碍.
- 肺功能 (支气管扩展后FEV1,IC/TLC,DLCO) 和CT扫描肺量化.
主要成果:
- 在25%的患者中存在肥胖 (BMI ≥30kg/m2).
- 呼吸障碍 (mMRC得分) 在BMI类别之间没有显著差异.
- 与非肥胖患者相比,肥胖患者的肺高通胀 (IC/TLC) 减少,肺气得分较低.
结论:
- 与非肥胖患者不同,呼吸困难与肥胖个体的COPD严重程度 (GOLD等级) 不相关.
- 在肥胖的COPD患者中,减少肺高通胀和不太严重的肺气可能会减轻呼吸障碍的进展.
- 肥胖的机械效应可能会改变COPD中典型的呼吸障碍-严重性关系.
相关概念视频
Chronic Obstructive Pulmonary Disease
1.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.2K
COPD: Management Using Bronchodilators and Corticosteroids
193
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
193
Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.7K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.7K
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K


